Drug Development on a Global Scale

from Running Through Walls · host Venrock, a venture capital firm

Following up on their discussion of COVID-19 vaccines and therapeutics, Venrock partner Bryan Roberts speaks with Mathai Mammen, Global Head of R&D at the Janssen Pharmaceutical Companies of Johnson & Johnson, about Mammen's career path and what differences he's found working on drug development in both small companies and large companies. Managing 14,000 people has its challenges, but the scale is incredible: J&J's products touch more than 1 billion people worldwide. They also discuss trends in gene editing and CRISPR thanks to machine learning and AI.

Episode metadata supplied by the publisher feed · Published Aug 19, 2020

Embed this episode

Attribution link and audio player

Ready to play

Drug Development on a Global Scale

0:00 32:06

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

CISO Perspectives (public) N2K Networks This season on CISO Perspectives, host Kim Jones explores some of the challenges of leading through uncertainty. We explore the complexity of the changing nature of regulation and working with the federal government, the evolution of privacy and fraud, and how emerging technologies like AI and quantum computing are changing cyber. When you don’t know what questions to ask, you’re afraid to ask, or don’t know who to ask, CISO Perspectives provides the foundation for learning in this brave new world.

Frequently Asked Questions

How long is this episode of Running Through Walls?

This episode is 32 minutes long.

When was this Running Through Walls episode published?

This episode was published on August 19, 2020.

Can I download this Running Through Walls episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!